Skip to main content
Back To Top Top Back To Top
This website publishes administrative rules on their effective dates, as designated by the adopting state agencies, colleges, and universities.

Rule 4729-16-05 | Drugs Compounded in a Fluid Therapy Pharmacy.

 

(A) For all non-sterile compounded prescriptions, the fluid therapy pharmacy shall comply with the United States pharmacopeia chapter <795> (01/01/2014).

(B) For all sterile compounded prescriptions, the fluid therapy pharmacy shall comply with the United States pharmacopeia chapter <797> (08/01/2014).

(C) When prepared in a fluid therapy pharmacy, drugs shall be dispensed by a pharmacist pursuant to an original patient-specific order issued by a prescriber.

(D) All prescriptions shall be issued pursuant to rule 4729-5-30 of the Administrative Code.

(E) All prescriptions shall be processed pursuant to rule 4729-5-21 of the Administrative Code.

(F) All drug orders for patients of a fluid therapy pharmacy shall include, but are not limited to, at least the following:

(1) Name and address of the patient;

(2) Name, strength, and dosage form of the drug;

(3) Directions for use, including route of administration;

(4) Date prescribed;

(5) Prescriber's positive identification;

(6) Length of therapy or total quantity to be dispensed.

(G) When prepared in a fluid therapy pharmacy, no compounded parenteral product prescription may be dispensed unless a label is affixed to the container in which such drug is dispensed and such label includes:

(1) The name and address of the pharmacy as it appears on the terminal distributor of dangerous drugs license;

(2) The telephone number of the pharmacy;

(3) The full name of the patient for whom the drug is prescribed;

(4) The full name of the prescriber;

(5) Directions for use of the drug which must include route of administration;

(6) The date of dispensing;

(7) Any cautions which may be required by federal or state law;

(8) The name and amount of the drug(s) added;

(9) The name and volume of the parenteral solution;

(10) The quantity of drug dispensed, if appropriate;

(11) Beyond use date;

(12) Storage conditions.

Supplemental Information

Authorized By: 3719.28, 4729.26
Amplifies: 3719.06, 3719.07, 4729.37
Five Year Review Date: 5/1/2020